Great West Life Assurance CO Travere Therapeutics, Inc. Transaction History
Great West Life Assurance CO
- $53.1 Billion
- Q2 2024
A detailed history of Great West Life Assurance CO transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 6,902 shares of TVTX stock, worth $69,365. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,902
Previous 6,902
-0.0%
Holding current value
$69,365
Previous $53,000
7.55%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding TVTX
# of Institutions
184Shares Held
89.8MCall Options Held
137KPut Options Held
181K-
Black Rock Inc. New York, NY7.64MShares$76.8 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.5MShares$75.4 Million0.8% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.37MShares$74.1 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$66.5 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.48MShares$45 Million1.14% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $645M
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...